MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
3. Government_Funders & Regulators
*Government: International
Europe
*Europe: Regions
*Western Europe
Ireland
*Industry: Ireland
Celgene (NASDAQ: CELG)
Finance & Acquisitions: Celgene
Parents
Celgene (NASDAQ: CELG)
Children
2009: Celgene Agrees to Acquire Gloucester Pharma for $340M Cash Upfront, $300M Later(2009)
2010: Celgene Pumps $130M Upfront into Agios Pharma for Drugs that Starve Cancer Cells (2010)
2010: Celgene strikes $2.9B deal to acquire Abraxis (2010)
2011: Acceleron Pharma raises $30M Celgene strategic financing (2011)
2011: Acceleron Pharma Secures $30 Million Private Financing (2011)
2011: Agios Pulls in $20M From Celgene, Under Extended Cancer Metabolism Partnership (2011)
2012: Celgene Pours $15M Into Acetylon, Takes “Observer” Role on Board (2012)
2013: Credit Suisse First Boston, HBM Healthcare Investments Ltd., Vulcan Capital, Celgene, Delphi Ventures, Novo A/S, The Column Group and other existing investors also participated in the transaction.(2013)
2013: In this round, investors Amgen Ventures (Nasdaq: AMGN), Celgene Corporation (Nasdaq: CELG), and EcoR1 Capital, joined existing investors Alexandria Venture Investments, DAG Ventures, Domain Associates, and Kleiner Perkins Caufield & Byers,(2013)
2015: Celgene To Buy Receptos For $7.2 Billion; Profit Soars CELG RCPT
2015: Celgene To Pay $1B For A Big Piece of Juno and T Cell Therapies
2015: Celgene To Pump $45M into Quanticel to Discover Cancer Drugs, Gets Option To Acquire (2011)
2016: Celgene's Stock Price Ready To Join The Sales Trend And Rock And Roll - Celgene Corporation (NASDAQ:CELG)
2018: Celgene confirms $9B Juno buyout, sees $3B sales for JCAR017
2018: Celgene hands over $101M in cash to launch a research collaboration with protein player Vividion – Endpoints News
2018: JP Morgan kicks off with a deal as Celgene pays $1.1B for Impact Biomedicines
2019: Bristol-Myers inks a $74B deal to buy out Celgene, expects $15B a year from late-stage pipeline – Endpoints News
2019: Bristol-Myers to buy Celgene in a $74 billion deal; Celgene shares surge_www.cnbc.com
Abraxis Bioscience
Acetylon Pharmaceuticals
Avila Therapeutics
CELG, Celgene Corp
Celgene Corporation (CELG) Analyst Research
Celgene_www.crunchbase.com
Delinia
EngMab
Gloucester Pharmaceuticals
Impact Biomedicines
Juno Therapeutics (JUNO)
Pharmion Corporation (NASDAQ: PHRM)
Quanticel Pharmaceuticals
Receptos-RCPT
Jumps
*Key People: Celgene
Organization & Developments: Celgene